Form D · Biotechnology
TamuroBio Inc.
Wayne, PA · CIK 0001801804
Offering snapshot reported Feb 7, 2020 · SEC filing
- Reported sold
- $4M Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 14, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 7, 2020 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-360028
Source: Form D, filed Feb 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Maxine Gowen | Director, Executive |
| Kristen Gowen Mac Donald | Executive |
| Leon Moulder, Jr. | Director, Executive |
| Asher Rubin | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
650 E. Swedesford Road Suite 190
Wayne, PA, 19087
Wayne, PA, 19087